8K + XBRL Form 4 - IGC Pharma, INC.

SEC

Filings

September 27, 2024

8K + XBRL Form 4

IGC Pharma, Inc. IGC on NYSE

Related Posts

IGC Pharma Inc 8K – Clinical Study Update Jun 17’25

June 17, 2025

FORM 10-Q

February 18, 2025

FORM TYPE 10-Q

November 12, 2024

CEO Update

igc pharma

IGC Pharma Inc 8K – Clinical Study Update Jun 17’25

June 17, 2025

IGC Pharma’s Puerto Rico CALMA Trial Site Offers Strategic Opportunity in High-Prevalence Alzheimer’s Market

May 22, 2025